Cipla is undergoing a big transformation and is doing something it once eschewedA difficult transformation is underway at Cipla, one of India’s largest and oldest pharma companies.
How Wockhardt Chairman Habil Khorakiwala plans to pull the company out of trouble45 years after he made a profound statement about dying only once, the chairman of Wockhardt would like to repeat it to investors, regulato...
Hyderabad braces for heavy rainfall during weekendAccording to IMD, “only 25 % areas across Telangana are likely to receive rainfall between 5-10 cms. Rest of the areas are expected to rece...
Lupin founder DB Gupta, a self made maverick who wanted to take out TB in India, deadGupta is survived by wife and five children (four daughters and a son) Vinita Gupta, the eldest daughter and Nilesh Gupta were handed over ...
InvaGen, Exelan acquisition will give Cipla manufacturing plant, R&D base in USCipla on Friday fulfilled a longstanding desire to expand its beachhead in the US by buying Hetero Pharma’s US business for about $550 mill...
Prabir Jha may become Cipla's new HR headPrabir Jha, who has recently quit Reliance Industries as its chief human resources officer, is reportedly considering an offer to join phar...
Death toll climbs to 1244 as intense heat wave continuesThe death toll due to intense heat wave sweeping across many parts of the country continued to mount and reached 1412 today, with only Andh...
Heat wave toll at 1242; AP, Telangana account for 1192 deathsAs per the latest figures, the toll due to heat wave in Andhra Pradesh stood at 852 while it was 340 in Telangana - together accounting for...
Cipla teams up with Gilead Lifesciences to make Hepatitis C drug under voluntary licenceOn the face of it, there is nothing wrong with this kind of a deal. Pharma companies ink many such pacts on a regular basis.
Corruption? Protection rackets more than crony capitalismCritics say economic liberalization has enriched only cronies through monopoly profits from political allocations of land, minerals and spe...
Kejriwal vs Ambani: Consumer may bear the brunt of the power crisisThe consumer may be the biggest casualty in the pubic spat between Arvind Kejriwal and Anil Ambani over power tariffs in Delhi.
Farmers should get access to larger markets to get benefits of APMC reformIt will also need to ensure that unfair practices do not take place. For that reason, there will still be a need for the APMC regulations.
19 to 48 in 3 years: India's Rs 5 crore club of professional CEOs swellsSeventeen new names debuted on the list in 2013, even as 13 fell off, making for a net addition of four CEOs — from 103 last year to 107 th...
- Pharma stocks rally after SC's Novartis verdict; analysts positive on DRL, Cipla, Natco
Pharma stocks surged 2-5 per cent after the Supreme Court dismissed Novartis AG's plea for getting its blood cancer drug patented in India.
Dr Reddy’s Laboratories founder Anji Reddy passes awayAnji Reddy, the pharmaceutical industry pioneer who helped establish India’s reputation as a supplier of inexpensive medicines to the world...
- SC gives reprieve to small shops in Delhi sealing case
In a major Diwali-eve reprieve for small and medium traders operating in residential areas, the Supreme Court on Friday allowed them the be...
- YK Alagh to be IRMA chairman
Well-known economist YK Alagh will replace Verghese Kurien as the chairman of the IRMA.